Vor Biopharma Inc.
VORNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $991.60M
- P/E (TTM)
- 1.58
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $6.50$30.38
- Volume (live)
- -
- Avg. volume (3M)
- 1.18M
Vor Biopharma (VOR) Stock Price & Financial Analysis
Vor Biopharma Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $17.95 - $18.81 |
|---|---|
| 52-Week High | $30.38 |
| 52-Week Low | $6.50 |
| Open | $18.67 |
| Volume (last close) | 720.92K |
| Average Volume (3M) | 1.18M |
| 50-Day MA | $21.35 |
|---|---|
| 200-Day MA | $17.08 |
| 1-Year Change | −31.77% |
| Market Cap | 991.60M |
|---|---|
| Shares Outstanding | 54.30M |
| P/E Ratio (TTM) | 1.58 |
| Price to Book (P/B) | -4.95 |
| EV/EBITDA | -0.83 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Vor Biopharma at a Glance
As of the Oct 23, 2026 close, Vor Biopharma (VOR) has a market capitalization of $991.60M. The stock trades at 1.6× trailing earnings.
As of its latest reported balance sheet, it holds $107.86M in cash and securities against $2.88M of debt, a net cash position of $104.98M.
Vor Biopharma does not currently pay a dividend.
The share price is down 31.8% over the past year. At $18.26 (the Oct 23, 2026 close) it sits within its 52-week range of $6.50 to $30.38, above its 200-day moving average of $17.08.
Based on 8 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $36.57, 100.3% above the Oct 23, 2026 close.
Frequently Asked Questions About Vor Biopharma
What is the current stock price for VOR?
As of the Oct 23, 2026 close, VOR stock trades at $18.26. The 52-week range is $6.50–$30.38, with a day range of $17.95–$18.81.
What is the P/E ratio for VOR?
As of the Oct 23, 2026 close, Vor Biopharma's trailing twelve-month (TTM) P/E ratio is 1.6, meaning investors pay $1.6 for every $1 of annual earnings. Vor Biopharma operates in the Healthcare sector.
Does VOR pay dividends?
Vor Biopharma does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for VOR?
Based on ratings from 8 professional analysts over the last 90 days, the consensus for VOR is Buy. The average 12-month price target is $36.57, a 100.3% upside from the Oct 23, 2026 close of $18.26.
What is the market cap of VOR?
As of the Oct 23, 2026 close, Vor Biopharma's market capitalization is $991.6M, classifying it as a small-cap company. Vor Biopharma operates in the Healthcare sector within the Biotechnology industry.